Search

everythinglearnresearchcommunity

for

Search:↓

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Minoxidil helped a boy regrow his hair after intense chemotherapy for leukaemia.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Dutasteride is approved to help manage prostate enlargement.

Enhancing immune response can improve cancer treatment effectiveness.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Radiation therapy is an effective treatment for severe scalp cellulitis with mild side effects and no long-term complications.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.